Precursor T-Cell Lymphoblastic Leukemia-Lymphoma - 25 Studies Found
Completed |
: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) : T-ALL, T-NHL (Lymphoblastic) : 2008-05-16 : Drug: Nelarabine 1500 mg/m² i.v., duration 2 hrs, day 1, 3, 5 |
Completed |
: Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden. : T-cell Acute Lymphoblastic Leukemia : 2013-09-07 |
Recruiting |
: A Study of LY3039478 in Combination With Dexamethasone in Participants With T-ALL/T-LBL :
|
Terminated |
: Trial of Nelarabine, Etoposide and Cyclophosphamide in Relapsed T-cell ALL and T-cell LL :
|
Active, not recruiting |
: Evaluation and Treatment of Tall Statured Girls : Constitutional Tall Stature : 2015-12-13 : Drug: Estradiol Estradiol containing compounds administered orally in a non-randomized manner. |
Recruiting |
: BL-8040 and Nelarabine for Relapsed or Refractory T-Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma :
|
Active, not recruiting |
: Study to Evaluate the Safety and Tolerability of Weekly Intravenous (IV) Doses of BMS-906024 in Subjects With Acute T-cell Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma :
|
Recruiting |
: Safety and Efficacy of Isatuximab in Lymphoblastic Leukemia : T-cell Type Acute Leukemia-Precursor T-lymphoblastic Lymphoma/Leukaemia : 2016-12-19 :
|
Recruiting |
: Combination Chemotherapy With or Without Bortezomib in Treating Younger Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or Stage II-IV T-Cell Lymphoblastic Lymphoma :
|
Active, not recruiting |
: Combination Chemotherapy in Treating Young Patients With Newly Diagnosed T-Cell Acute Lymphoblastic Leukemia or T-cell Lymphoblastic Lymphoma :
|